Dacomitinib in lung cancer: a “lost...

Drug Design Development and Therapy 2015 / 10

Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?

Ou, Sai-Hong, Soo, Ross
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S52787
Date:
October, 2015
File:
PDF, 555 KB
english, 2015
Conversion to is in progress
Conversion to is failed